Economics of devices

Area of Science:

• Medical Device Economics
• Cardiovascular Engineering
• Health Technology Assessment

Background:

• The development of mechanical circulatory support (MCS) devices presents significant economic challenges.
• High costs are associated with years of research, development, testing, and navigating regulatory, reimbursement, and market acceptance barriers.
• The current market for long-term MCS is primarily limited to bridge to transplantation, representing a $100 million market, with increasing competition.

Purpose of the Study:

• To analyze the economic landscape of mechanical circulatory support devices.
• To identify key factors influencing the financial viability of MCS technology development and adoption.
• To explore strategies for enhancing the economic sustainability of the MCS industry.

Main Methods:

• Economic analysis of MCS device development and market factors.
• Review of regulatory, reimbursement, and clinical acceptance challenges.
• Market size estimation for current and potential MCS applications.

Main Results:

• MCS device development is a capital-intensive, high-risk undertaking.
• The existing market for long-term support is constrained, primarily serving the bridge-to-transplantation population.
• Increasing competition from new devices entering clinical trials.

Conclusions:

• The economic viability of the MCS industry hinges on expanding clinical indications.
• Exploring definitive or destination therapy offers a significant growth opportunity.
• Other potential applications like bridge to recovery and assisted medical therapies could further bolster the industry's economic health.